| Title | Author(s) | Year | View Count |
 | Epidemiology and potential associated risk factors of drug-related problems in hospitalised children in the United Kingdom and Saudi Arabia | Rashed, AN; Neubert, A; Tomlin, S; Jackman, J; Alhamdan, H; Alshaikh, A; Attar, A; Aseeri, M; Wilton, L; Wong, ICK | 2012 | 44 |
 | Persistence of pharmacological treatment into adulthood for ADHD patients who started treatment in childhood or adolescence in UK primary care | McCarthy, S; Wilton, L; Murray, M; Hodgkins, P; Asherson, P; Wong, ICK | 2012 | 77 |
 | The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care | McCarthy, S; Wilton, L; Murray, ML; Hodgkins, P; Asherson, P; Wong, ICK | 2012 | 69 |
| Montelukast and suicide: causality assessment using Spontaneous Reports and Bradford Hill Guidelines | Iessa, N; Star, K; Wilton, L; Curran, S; Edwards, R; Aronson, J; Murray, M; Besag, F; Wong, ICK | 2011 | 68 |
| Persistence of pharmacological treatment into adulthood for ADHD patients who started treatment in childhood or adolescence in UK primary care | McCarthy, S; Wilton, L; Murray, M; Hodgkins, P; Asherson, P; Wong, ICK | 2011 | 71 |
| The epidemiology of pharmacologically-treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care | McCarthy, S; Wilton, L; Murray, ML; Hodgkins, P; Asherson, P; Wong, ICK | 2011 | 55 |
|
